Clovis Oncology, Inc. (CLVS) Social Stream



Clovis Oncology, Inc. (CLVS): $2.19

-0.14 (-6.01%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CLVS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

Clovis Oncology Inc (CLVS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CLVS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 3 $8 $6 $7 $2.33 200.43%
2021-11-04 4 $8 $4.75 $6.25 $2.33 168.24%

The Trend in the Analyst Price Target


CLVS's average price target has moved down $0.1 over the prior 129 days.

CLVS reports an average of 18.08% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-04 3 8 6 7.00 4.57 53.17%
2021-02-01 8 15 3 7.33 8.46 -13.36%
2021-04-25 5 13 3 7.13 6.09 17.08%
2021-08-14 5 10 3 5.90 4.78 23.43%
2021-08-07 5 10 3 5.90 4.97 18.71%

CLVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.67 1 0 1 0 0 3

The Trend in the Broker Recommendations


CLVS's average broker recommendation rating improved by 0.58 over the prior 31 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Clovis Oncology Inc's average analyst price target is greater than 10.06% of all US stocks.
  • Clovis Oncology Inc's upside potential (average analyst target price relative to current price) is higher than 181.29% of stocks in the mid market cap category.
  • CLVS has a higher number of analysts covering the stock than 24.9% of stocks in the mid market cap category.
  • In the context of stocks in the mid market cap category, Clovis Oncology Inc's variance in analysts' estimates is lower than -9.65% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Clovis Oncology Inc are CERE, CCXI, and BPMC.

Make investment decisions regarding CLVS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5931 seconds.